W. Mark Watson's Net Worth
-$120 Thousand
Who is W. Mark Watson?
W. Mark Watson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, HedgePath Pharmaceuticals, Inc., Vaxart, Inc., TEKLA HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, TEKLA LIFE SCIENCES INVESTORS, and SYKES ENTERPRISES INC.
SEC CIK
W. Mark Watson's CIK is 0001612372
Past Insider Trading and Trends
2018 was W. Mark Watson's most active year for acquiring shares with 11 total transactions. W. Mark Watson's most active month to acquire stocks was the month of July. 2017 was W. Mark Watson's most active year for disposing of shares, totalling 6 transactions. W. Mark Watson's most active month to dispose stocks was the month of February. 2022 saw W. Mark Watson paying a total of $329,021.60 for 232,011 shares, this is the most they've acquired in one year. In 2020 W. Mark Watson cashed out on 46,000 shares for a total of $145,640.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
InvestorW. Mark Watson used to own units in Common Stock but no longer holds any shares there.acquired a total of 102,163 shares in BIODELIVERY SCIENCES INTERNATIONAL INC, W. also disposed a total of 103,663 shares of BIODELIVERY SCIENCES INTERNATIONAL INC equalling to $67,340.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -90.66K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +9.26% | 7.68K |
—
|
—
| 90.66K |
Jan 27
| |||
Form 4
| +56.63% | 30K |
—
|
—
| 82.98K |
Aug 6
| |||
Form 4
| -19.70% | -13.00K |
$5.18 | -$67,340.00 | 52.98K |
Aug 17
| |||
Form 4
| +83.38% | 30K |
—
|
—
| 65.98K |
Aug 7
| |||
Form 4
| +220.10% | 24.74K |
—
|
—
| 35.98K |
Aug 13
| |||
Form 4
| +649.33% | 9.74K |
—
|
—
| 11.24K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HedgePath Pharmaceuticals, Inc. (INTI) Snapshot price: $0.068975
InvestorW. Mark Watson owns 553,600 units of Common Stock which is worth $38,184.56. In the year 2014 W. Mark Watson filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +5,436.00% | 543.6K |
$0.34 | -$121,176.00 | 553.6K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
∞
| 10K |
$0.13 | $1,300.00 | 10K |
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vaxart, Inc. (VXRT) Snapshot price: $0.88
InvestorW. Mark Watson owns 78,125 units of Common Stock which is worth $68,750.00. From 2022 to 2024 W. Mark Watson acquired a total of 78,125 shares in Vaxart, Inc. at a cost of $28,718.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.41% | 20K |
$0.68 | $13,578.00 | 78.13K |
Jun 18
| |||
Form 4
| +37.98% | 16K |
—
|
—
| 58.13K |
Jun 11
| |||
Form 4
| +21.22% | 7.38K |
—
|
—
| 42.13K |
Jun 26
| |||
Form 4
|
∞
| 20K |
$0.76 | $15,140.00 | 20K |
Dec 28
| |||
Form 4
|
∞
| 14.75K |
—
|
—
| 14.75K |
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TEKLA HEALTHCARE INVESTORS (HQH) Snapshot price: $18.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tekla Healthcare Opportunities Fund (THQ) Snapshot price: $21.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||